Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL6 | P41182 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | GLP1R | P43220 | 1/20 | 0.30 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4835877 | 0.87 | IDH1 (0.33) | TDP1MEN1ALDH1A1MAPTPKM | |
| SCHEMBL5751003 | 0.78 | — | — | |
| SCHEMBL14000740 | 0.78 | GLP1R (0.33) | MAPK14GLP1R | |
| SCHEMBL4826868 | 0.76 | GLP1R (0.42) | ALDH1A1RAB9AGLP1R | |
| SCHEMBL4021311 | 0.72 | TRPM8 (0.47) | TDP1MEN1MAPTRAB9AKMT2A | |
| SCHEMBL14000746 | 0.69 | IDH1 (0.34) | KCNH3 | |
| SCHEMBL3568691 | 0.69 | IDH1 (0.39) | MEN1ALDH1A1KMT2A | |
| SCHEMBL13114687 | 0.69 | IDH1 (0.39) | MEN1ALDH1A1KMT2A | |
| SCHEMBL4835820 | 0.69 | LMNA (0.30) | GAA | |
| SCHEMBL14000744 | 0.69 | LMNA (0.30) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060199801-A1 | Heterobicyclic compounds used as fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-07 | — | — | US | disclosed |
| EP-1620436-A1 | HETEROBICYCLIC COMPOUNDS USED AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004092175-A1 | HETEROBICYCLIC COMPOUNDS USED AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060199801-A1 | Heterobicyclic compounds used as fungicides | CBR3, CBR1, CYP2A6 | BCL6 597/4885TDP1 3389/4885MEN1 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.